Equities researchers at Leerink Partnrs reduced their FY2025 earnings estimates for ICON Public in a research report issued ...

March 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor conferences in March: Leerink Global ...

PharmaCord is a Jeffersonville, Indiana-based provider of patient services for the biopharmaceutical industry, and Mercalis, a Morrisville, North Carolina-based provider of life sciences and ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Despite posting disappointing top revenue and earnings misses for Q4 last week, Zymeworks (ZYME) has seen its shares rally over 5%, thanks in ...

Robert Truckenmiller will serve as CEO of the combined company ... Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel, and Jefferies LLC and Leerink Partners are serving as financial ...

Rob will share additional color on this trial ... [Operator Instructions] And your first question comes from the line of Marc Goodman with Leerink. Please go ahead. Thanks, Bruce.

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), ...

For Hims and other compounders, this development starts the clock on having unfettered market access to Novo's drugs, Leerink Partners ... out of shortage. Robert Califf, who was FDA ...